Valeria M Zakharova

Title: Valeria M Zakharova: Innovator in Antiviral Drug Development

Introduction

Valeria M Zakharova is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of antiviral drug development, holding 2 patents that focus on innovative methods to enhance the efficacy of nucleotide analogue drugs.

Latest Patents

Her latest patents include a method to improve the antiviral activity of nucleotide analogue drugs. This invention involves an amino acid conjugate of a cyclic or acyclic nucleoside phosphonate, which is useful as an antiviral compound. The conjugate may include a long chain alkyl group on the carboxamide group of the tyrosine residue. Additionally, she has developed tyrosine-based prodrugs of antiviral agents, which include a method of synthesizing such conjugates based on Boc-protected amino acids or dipeptides. These advancements provide methods for inhibiting viral replication and treating viral infections.

Career Highlights

Valeria M Zakharova is affiliated with the University of Southern California, where she continues her research and development in the field of antiviral therapies. Her work has garnered attention for its potential impact on treating viral infections.

Collaborations

She has collaborated with notable colleagues, including Charles E McKenna and Boris A Kashemirov, further enhancing the scope and depth of her research.

Conclusion

Valeria M Zakharova's innovative work in antiviral drug development showcases her commitment to advancing medical science. Her contributions are paving the way for new treatments that could significantly benefit public health.